FDA.reportPublic FDA data

Twirla Weekly Replacement Transdermal System

RxCUI
2396258
RxNorm name
Twirla Weekly Replacement Transdermal System
Display name
Twirla Weekly Replacement Transdermal System
Full name
Twirla Weekly Replacement Transdermal System
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:18

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
TwirlaLEVONORGESTREL/ETHINYL ESTRADIOLAgile Therapeutics, Inc.bcaf8db0-1750-425d-b008-255b5e7a9cc62026-06-30Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2396258

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
bcaf8db0-1750-425d-b008-255b5e7a9cc6Twirla Weekly Replacement Transdermal System [PSN] · 168 HR ethinyl estradiol 0.00125 MG/HR / levonorgestrel 0.005 MG/HR Transdermal System [Twirla] [SBD] · Twirla Weekly Replacement Transdermal System [SY]37These highlights do not include all the information needed to use TWIRLA ® safely and effectively. See full prescribing information for TWIRLA. TWIRLA (levonorgestrel and ethinyl estradiol) transdermal system Initial U.S. Approval: 1968 (norgestrel and ethinyl estradiol)20240703